The stock market performance of Regulus Therapeutics Inc has been very steady. Over the last year, the company’s stock hit its highest at $3.79 on 03/12/24, while the lowest price during the same time frame was $1.08, recorded on 01/17/24.
52-week price history of RGLS Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Regulus Therapeutics Inc’s current trading price is -57.52% away from its 52-week high, while its distance from the 52-week low is 49.07%. The stock’s price range during this period has fluctuated between $1.08 and $3.79. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.41 million for the day, which was evidently higher than the average daily volume of 0.33 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Regulus Therapeutics Inc (RGLS) has experienced a quarterly decline of -10.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 105.41M and boasts a workforce of 30 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.7243, with a change in price of -0.6200. Similarly, Regulus Therapeutics Inc recorded 641,678 in trading volume during the last 100 days, posting a change of -27.80%.
RGLS Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RGLS stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
RGLS Stock Stochastic Average
Regulus Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 46.00%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 53.66%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 30.89% and 20.05%, respectively.
RGLS Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price increase of 25.78%. However, over the past six months, we’ve seen a stronger performance of -30.00%. The price of RGLS fallen by 2.55% over the last 30 days. And in the last five days, it has surged by 8.05%.
